Overview of Ac‑225 PSMA therapy, what real patient cases can illustrate about the treatment pathway, and key steps for eligibility review and choosing a center.
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...
Consuming more plant-based foods following prostate cancer diagnosis was associated with improved sexual function, among other QOL domains.
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
UroLift may succeed in relieving your enlarged prostate symptoms and may allow you to stop taking medication. However, not ...
There is a simple discount patient access scheme for talazoparib and a commercial access agreement for enzalutamide. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal ...
In a timely development that is drawing strong attention across the men’s wellness sector, a new supplement—Men Balance Pro—has been officially announced for broader availability in 2026. The ...
The global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period. This growth is ...
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...
It’s among the most common cancers affecting older men. But a diagnosis today isn’t always what it seems. By David Dodge An estimated one in eight men will be diagnosed with prostate cancer in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results